Crowdonomics
All companies
Add Your Labs logo

Add Your Labs

Operating

TrueGen Health, Inc.

Healthcare · Biotech · Hinsdale, IL · Founded 2021

Next generation in medical laboratory software

Post-money valuation
$7.1M
As of Dec 2022 · from Add Your Labs Common Stock 2 · pre-money + amount raised, not a traded price
Total raised
$48,169
Across 2 rounds since 2022
Latest share price
$2.00
Add Your Labs Common Stock 2 offering price

Financials

FY2019–FY2022 · from SEC filings · hover any figure for its source
$0
2019
$118K
−$32K
2020
$220K
−$20K
2021
$110K
−$134K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$0
$117,588
$220,483
$109,502
Cost of goods sold
$0
$56,711
$81,267
$91,990
Gross margin
52%
63%
16%
Net income
$0
-$31,979
-$20,142
-$134,181
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$17,621
$771
$58,172
Accounts receivable
$0
$0
$220,483
$109,502
Total assets
$0
$220,907
$248,760
$392,195
Short-term debt
$0
$9,785
$14,070
$45,389
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$9,785
$14,070
$45,389
Other
Headcount
2
2
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$7.1M
post-money
Add Your Labs Common Stock 2

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Add Your Labs Common Stock 2ClosedReg CF · Common Equity · via StartEngine
Raised $48.2K / $124KInvestors 39Post-money $7.1M
Reg CF Offering (2022)WithdrawnReg CF · Common Equity · via Fundify Portal, LLC
Raised $0 / $249.9K

Team

2 people
David HainesFounder
Co-founder and Lead Developer

Full-stack developer for Add Your Labs Taught full-stack development to military personnel Product development in healthcare and integrated clinical testing David is motivated to apply his skills to prosocial development

Frank AdamoFounder
Founder and CEO

19 years of experience in healthcare (clinical testing) at Abbott Labs, J&J, and PerkinElmer Developed & launched new clinical testing products globally Founded (2017) and launched (2020) Visible Genomics Founded and launched Add Your Labs (2020)

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 5 annual reports (FY2021–FY2025)

39 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-ARMay 1, 20230001665160-23-001071
    EDGAR
  • Form C-UJan 3, 20230001665160-23-000003
    EDGAR
  • Form C/ADec 20, 20220001665160-22-003103
    EDGAR
  • Form DDec 14, 20220001901311-22-000005
    EDGAR
  • Form CSep 21, 20220001665160-22-002459
    EDGAR
  • Form C-WMay 3, 20220001901311-22-000004
    EDGAR
  • Form C/AMar 18, 20220001901311-22-000003
    EDGAR
  • Form C/AMar 1, 20220001910093-22-000002
    EDGAR
Source: ManualCIK 0001901311DEShare price $2.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.